Highly secreted tryptophanyl tRNA synthetase 1 as a potential theranostic target for hypercytokinemic severe sepsis (vol 16, pg 40, 2023)

Abstract

The Acknowledgements section is corrected from: This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) of the Korean government (MSIT), Republic of Korea, grant numbers NRF-2019M3E5D5064771, the Korea Health Technology R&D Project by the Korea Health Industry Development Institute (KHIDI) of the Ministry of Health & Welfare, Republic of Korea, grant number HI20C0015, and HI122C10883, Daegu-Gyeongbuk/Osong Medical Cluster R&D Project funded by the Ministry of Science and ICT, the Ministry of Trade, Industry and Energy, the Ministry of Health & Welfare, Republic of Korea, grant number HI19C0763, and Korea Drug Development Fund funded by Ministry of Science and ICT, Ministry of Trade, Industry, and Energy, and Ministry of Health and Welfare, Republic of Korea, grant number RS-2022-00166575. To (see changes in bold) This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) of the Korean government (MSIT), Republic of Korea, grant numbers NRF-2019M3E5D5064771, the Korea Health Technology R&D Project by the Korea Health Industry Development Institute (KHIDI) of the Ministry of Health & Welfare, Republic of Korea, grant number HI20C0015, and HI22C1883, Daegu-Gyeongbuk/Osong Medical Cluster R&D Project funded by the Ministry of Science and ICT, the Ministry of Trade, Industry and Energy, the Ministry of Health & Welfare, Republic of Korea, grant number HI19C0763, and Korea Drug Development Fund funded by Ministry of Science and ICT, Ministry of Trade, Industry, and Energy, and Ministry of Health and Welfare, Republic of Korea, grant number RS-2022-00166575. This change does not affect the text or interpretation of the article.